Supplementary tables
Supplementary Table S1 -Several experimentally identified phosSNPs. In 2006, Erxleben et al. (The Armstrong group) firstly raise the term "phosphorylopathy" to describe human genetic variation that results in aberrant regulation of protein phosphorylation (1) . For simplicity, we refined the term "phosphorylopathy" as phosSNP (Phosphorylation-related SNP). a. Exp. Type, the phosSNP types identified by experimental approaches; b. Pre. Type, the phosSNP types predicted in this work. For example, the K897T nsSNP of human ERG1/KCNH2/Kv11.1 channel protein was experimentally verified as a type I (+) phosSNP to create a new AKT phosphorylation site to prolong the QT interval of cardiac myocytes (2), while our predictions further pointed that this phosSNP might induce changes of PK types for adjacent phosphorylation sites (Type III). Users could use RefSeq ID, eg., NM_000238 to query the PhosSNP database for more detailed information.
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NM_000621|rs1058576|pos=421|TCT->TTT|S->F 1-1-, 3
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